Elanco Animal Health Net Debt Growth & History (ELAN)
Elanco Animal Health's net debt was $3.60B for fiscal 2025.
View full Elanco Animal Health company overviewElanco Animal Health annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $3.60B | −$380.0M | −9.56% |
| 2024 | 2024-12-31 | $3.98B | −$1.59B | −28.54% |
| 2023 | 2023-12-31 | $5.56B | −$69.0M | −1.22% |
| 2022 | 2022-12-31 | $5.63B | −$209.0M | −3.58% |
| 2021 | 2021-12-31 | $5.84B | $21.6M | +0.37% |
| 2020 | 2020-12-31 | $5.82B | $3.71B | +176.32% |
| 2019 | 2019-12-31 | $2.11B | $108.9M | +5.45% |
| 2018 | 2018-12-31 | $2.00B | $2.32B | — |
| 2017 | 2017-12-31 | −$323.4M | — | — |
Elanco Animal Health quarterly net debt
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.39B | −$282.0M | −7.68% |
| Q1 2026 | 2026-03-31 | $3.56B | −$345.0M | −8.83% |
| Q4 2025 | 2025-12-31 | $3.60B | −$380.0M | −9.56% |
| Q3 2025 | 2025-09-30 | $3.52B | −$348.0M | −9.00% |
| Q2 2025 | 2025-06-30 | $3.67B | −$1.59B | −30.23% |
| Q1 2025 | 2025-03-31 | $3.91B | −$1.51B | −27.90% |
| Q4 2024 | 2024-12-31 | $3.98B | −$1.59B | −28.54% |
| Q3 2024 | 2024-09-30 | $3.87B | −$1.67B | −30.20% |
| Q2 2024 | 2024-06-30 | $5.26B | −$435.0M | −7.64% |
| Q1 2024 | 2024-03-31 | $5.42B | −$282.0M | −4.95% |
| Q4 2023 | 2023-12-31 | $5.56B | −$69.0M | −1.22% |
| Q3 2023 | 2023-09-30 | $5.54B | $99.0M | +1.82% |
| Q2 2023 | 2023-06-30 | $5.70B | $139.0M | +2.50% |
| Q1 2023 | 2023-03-31 | $5.70B | −$90.0M | −1.55% |
| Q4 2022 | 2022-12-31 | $5.63B | −$209.0M | −3.58% |
| Q3 2022 | 2022-09-30 | $5.44B | −$440.0M | −7.48% |
| Q2 2022 | 2022-06-30 | $5.56B | $39.0M | +0.71% |
| Q1 2022 | 2022-03-31 | $5.79B | $146.0M | +2.59% |
| Q4 2021 | 2021-12-31 | $5.84B | $21.6M | +0.37% |
| Q3 2021 | 2021-09-30 | $5.88B | $400.9M | +7.32% |
| Q2 2021 | 2021-06-30 | $5.52B | $4.85B | +729.25% |
| Q1 2021 | 2021-03-31 | $5.65B | $4.79B | +559.89% |
| Q4 2020 | 2020-12-31 | $5.82B | $3.71B | +176.32% |
| Q3 2020 | 2020-09-30 | $5.48B | $3.35B | +156.97% |
| Q2 2020 | 2020-06-30 | $665.3M | −$1.44B | −68.40% |
| Q1 2020 | 2020-03-31 | $855.6M | −$1.42B | −62.39% |
| Q4 2019 | 2019-12-31 | $2.11B | $108.9M | +5.45% |
| Q3 2019 | 2019-09-30 | $2.13B | −$45.9M | −2.11% |
| Q2 2019 | 2019-06-30 | $2.11B | — | — |
| Q1 2019 | 2019-03-31 | $2.27B | — | — |
| Q4 2018 | 2018-12-31 | $2.00B | $2.32B | — |
| Q3 2018 | 2018-09-30 | $2.18B | — | — |
| Q4 2017 | 2017-12-31 | −$323.4M | — | — |
Elanco Animal Health net debt trends
Over the last five fiscal years, Elanco Animal Health's net debt decreased from $5.82B to $3.60B, a change of −$2.22B. The latest reported quarter, Q2 2026, shows $3.39B.
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Elanco Animal Health source filings ↗